Semaglutide Taken Once Weekly in People With Type 2 Diabetes (SUSTAIN FORTE)

In by ECIR

Semaglutide Taken Once Weekly in People With Type 2 Diabetes (SUSTAIN FORTE)

  • This field is for validation purposes and should be left unchanged.

A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes (SUSTAIN FORTE)

clinicaltrials.gov

Eligibility

Inclusion Criteria

• Male or female patient age ≥ 18 years
• Diagnosed with type 2 diabetes mellitus (T2DM)
• HbA1c of 8-10%
• Current treatment with any metformin formulations alone or in combination with sulfonylureas (SU)

Exclusion Criteria

• eGFR value of <30 mL/min • Uncontrolled and potentially unstable diabetic retinopathy or maculopathy

Back to Current Studies